Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. egypt
  4. knee replacement
Show results for
Products
Services
Applications

Companies

News
Articles
Magazines
Downloads
Videos

Refine by
Date

  • Older

Knee Replacement Articles & Analysis

40 news found

New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA

New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA

In the prospective observational XARENO study, after a two year follow up period, Xarelto was associated with a reduced risk of adverse kidney outcomes and all-cause mortality in patients with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD), compared to vitamin K antagonists (VKA) XARENO evaluated the impact of Xarelto in patients with NVAF and CKD, given that ...

ByBayer AG


Caira Surgical to Participate in Upcoming Investor Conferences

Caira Surgical to Participate in Upcoming Investor Conferences

Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that Jon Greenwald, Chief Executive Officer, and Irina Benimovich, Chief Financial Officer, will conduct investor meetings and host presentations at the upcoming CG 2023 Musculoskeletal Conference and LSI USA '23 partnering event. March 7 – CG 2023 Musculoskeletal ...

ByCaira Surgical


Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

As one of the leading chemical manufacturers and suppliers globally, Alfa Chemistry is well-prepared to provide a number of active pharmaceutical ingredients (APIs), such as donepezil and dexmedetomidine hydrochloride, for customers worldwide ranging from lab to commercial scale. Earlier this month, the company announced that three other APIs had been introduced for its global customers as well, ...

ByAlfa Chemistry


Announcement – RSIP Vision Presents Successful Preliminary Results from Clinical Study of 2D-to-3D Knee Bones Reconstruction

Announcement – RSIP Vision Presents Successful Preliminary Results from Clinical Study of 2D-to-3D Knee Bones Reconstruction

RSIP Vision, an experienced developer of groundbreaking AI technologies for medical imaging, today reveals preliminary results from an ongoing clinical study for the evaluation of the reconstruction of a 3D knee model from 2D X-ray images at Assuta Medical Center in Tel Aviv. This tool is based on novel, patent-pending technology, implementing advanced artificial intelligence (AI) to produce an ...

ByRSIP Vision


Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the U.S. Food and Drug Administration. The NUsurface® Meniscus Implant is the first “artificial meniscus” to be marketed in Europe and, if cleared by the FDA, would be the first ...

ByActive Implants LLC


Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego

Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s SUN (Safety Using NUsurface) trial is now underway in San Diego. Dr. Scott A. Hacker at Grossmont Orthopaedic Medical Group is the only physician in San Diego County – and the center is one of just 10 sites nationwide – participating in the SUN clinical trial to evaluate the ...

ByActive Implants LLC


100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant

100th Patient Enrolled in Clinical Trials for Active Implants’ NUsurface Meniscus Implant

Active Implants, LLC, a company that develops orthopedic implant solutions, today announced enrollment of the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorating meniscus tissue. The surgery was performed by orthopedic surgeon Dr. Wayne Gersoff of Advanced Orthopedics & Sports Medicine ...

ByActive Implants LLC


Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant

Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant

Dr. Scott A. Hacker, an expert in arthroscopic surgery, total joint replacements, sports medicine and fracture care, and Active Implants, a company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedure in San Diego has been performed. Dr. Hacker is the only physician in San Diego County – and Grossmont Orthopedic Medical Group is one of ...

ByActive Implants LLC


Photodisinfection successfully eradicates pathogens associated with replacement joint infections

Photodisinfection successfully eradicates pathogens associated with replacement joint infections

A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the key pathogens in biofilms associated with implantable joint infections, with no reported regrowth. These results were presented at the recent Swiss Society for Microbiology (SSM) Annual Congress 2022 in Lausanne, Switzerland. ...

ByOndine Biomedical Inc


Rivaroxaban (Xarelto) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation

Rivaroxaban (Xarelto) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation

The Ministry of Health, Labor and Welfare in Japan has approved the use of the oral Factor Xa inhibitor rivaroxaban (Xarelto™) (2.5 mg twice daily, used in combination with aspirin 81-100 mg once daily) to treat patients with peripheral artery disease (PAD) after revascularization. The approval is based on data from the Phase III VOYAGER PAD trial. This study demonstrated a positive ...

ByBayer AG


Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical

Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical

THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, is pleased to announce that Stefan Kreuzer, M.D.*, of INOV8 Surgical, a leading ambulatory surgical center (ASC) in Houston specializing in outpatient total joint procedures, is approaching a key milestone with THINK’s active robot technology. Dr. Kreuzer has performed nearly 90 procedures** with the ...

ByThink Surgical Inc.


Centennial Hills Hospital Medical Center is the First Hospital in the Western United States to Perform a Total Knee Replacement Procedure with THINK Surgical’s Leading Robot System

Centennial Hills Hospital Medical Center is the First Hospital in the Western United States to Perform a Total Knee Replacement Procedure with THINK Surgical’s Leading Robot System

THINK Surgical, Inc., an innovator in the field of orthopedic robotic surgery, proudly announced Centennial Hills Hospital Medical Center became the first facility in the western United States to utilize the latest iteration of the TSolution One robot from THINK Surgical. The system, manufactured by the Fremont, CA – based company features a true, active robot which supports a choice of ...

ByThink Surgical Inc.


DePuy Synthes Further Reimagines Knee Restoration with the Addition of Two New Innovations to the ATTUNE™ Knee Portfolio

DePuy Synthes Further Reimagines Knee Restoration with the Addition of Two New Innovations to the ATTUNE™ Knee Portfolio

Today, Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, is adding two new innovations to its kinematically advanced and proveni,ii,iii,iv,v,vi ATTUNE™ Knee portfolio: the ATTUNE™ Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology and the ATTUNE™ Medial Stabilized Knee System. Approximately 20 ...

ByJohnson & Johnson Medical Devices Business Services, Inc.


Hackensack University Medical Center is the First Hospital on the East Coast to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System

Hackensack University Medical Center is the First Hospital on the East Coast to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System

Hackensack University Medical Center, a national leader in orthopedic care and robotic surgery, recently completed the first total knee replacement on the East Coast using the newest generation of the TSolution One robot from THINK Surgical. The system, manufactured by the Fremont, CA – based company features a true, active robot which supports a choice of knee implants from multiple ...

ByThink Surgical Inc.


Caira secures $5M financing to develop new standard of care in orthopedics

Caira secures $5M financing to develop new standard of care in orthopedics

Caira Surgical announced its latest influx of $5M seed capital in an oversubscribed series seed financing that closed last month. Caira's investor syndicate includes smart-money venture and strategic MedTech investors. Caira's proprietary technology seeks to revolutionize the usability, safety, and accessibility of advanced surgical navigation and robotics for orthopedic surgery. The company's ...

ByCaira Surgical


U.S. FDA approves Xarelto to treat venous thromboembolism (VTE) and to prevent VTE in children

U.S. FDA approves Xarelto to treat venous thromboembolism (VTE) and to prevent VTE in children

Xarelto is the only Factor Xa anticoagulant FDA approved for pediatric patients and offers a flexible weight-based dosing Xarelto is available in both oral tablet and liquid suspension formulations for use in appropriate children less than 18 years of age Convenient liquid formulation advances standard of care for children; alleviates administration challenges found with injectable ...

ByBayer AG


Microport Orthopedics announces first successful total knee replacement performed in the U.S. using Pixee Medical’s Knee+ Augmented-Reality Platform

Microport Orthopedics announces first successful total knee replacement performed in the U.S. using Pixee Medical’s Knee+ Augmented-Reality Platform

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the successful completion of the first surgery in the U.S. utilizing Pixee Medical, an FDA-cleared augmented reality surgical application for assistance in total knee arthroplasties. The surgery was performed by Dr. Antonia F. Chen, M.D., M.B.A., an orthopedic surgeon at Brigham and Women’s ...

ByMicroport Orthopedics Inc.


Golden Valley Memorial Healthcare is First Hospital in Missouri to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System

Golden Valley Memorial Healthcare is First Hospital in Missouri to Perform Total Knee Replacement Procedures with THINK Surgical’s Next-Generation Robot System

THINK Surgical, Inc., a leading innovator in the field of orthopedic robotic surgery, announced that Golden Valley Memorial Healthcare (GVMH) in Clinton, MO is among the first healthcare facilities to employ the second-generation TSolution One® robot for total knee arthroplasty (TKA). James Womack, M.D., a board-certified orthopedic surgeon and fellow of the American Association of Hip and ...

ByThink Surgical Inc.


World’s First “Artificial Meniscus” Available in Israel

World’s First “Artificial Meniscus” Available in Israel

Active Implants LLC, a company that develops orthopedic implant solutions, today announced that two patients in Israel have undergone knee surgery for the company’s NUsurface® Meniscus Implant – the first “artificial meniscus” to be marketed in the Middle East. Until now, the NUsurface Implant was only available in Israel in clinical trials. The procedures were ...

ByActive Implants LLC


Microport Orthopedics Welcomes C Lowry Barnes, M.D. to Leadership Team as Medical Director

Microport Orthopedics Welcomes C Lowry Barnes, M.D. to Leadership Team as Medical Director

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces that C. Lowry Barnes, MD, Chair of Orthopaedics at the University of Arkansas for Medical Sciences Health, has officially joined the company’s leadership team as Medical Director. Dr. Barnes is a board-certified, fellowship-trained total joint surgeon with a special interest in hip and knee ...

ByMicroport Orthopedics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT